{
  "id": 12149185,
  "title": "STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market",
  "url": "https://urgent.news/2026/10/05/stat-vaxcyte-claims-success-in-bid-to-beat-pfizer-and-merck-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-05T12:19:11.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/10/05/vaxcyte-pneumococcal-vaccine-study-pfizer-merck/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the biotech to compete with Pfizer and Merck.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Guggenheim raises Vaxcyte stock price target on vaccine trial win",
        "url": "https://urgent.news/2026/10/05/guggenheim-raises-vaxcyte-stock-price-target-on-vaccine-trial-win",
        "published": "2026-10-05T11:14:55.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}